Orthofix Medical Inc. Common Stock (DE) (OFIX) is a publicly traded Healthcare sector company. As of May 21, 2026, OFIX trades at $10.94 with a market cap of $490.72M and a P/E ratio of -8.10. OFIX moved +0.58% today. Year to date, OFIX is -20.74%; over the trailing twelve months it is +1.33%. Its 52-week range spans $10.24 to $20.73. Analyst consensus is strong buy with an average price target of $17.25. Rallies surfaces OFIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Orthofix’s Q1 Loss of $20.9M on $196.7M Revenue; Spine Fixation Up 6%: Orthofix reported Q1 net loss of $20.9 million (52 cents per share) on $196.7 million revenue, with adjusted EPS loss of 12 cents. Spine Fixation grew 6% on 7D FLASH navigation, top 30 distributors delivered 27% growth and full-year revenue guides $850–860 million with H2 growth ramp to 6%.
| Metric | Value |
|---|---|
| Price | $10.94 |
| Market Cap | $490.72M |
| P/E Ratio | -8.10 |
| EPS | $-1.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $20.73 |
| 52-Week Low | $10.24 |
| Volume | 6.32K |
| Avg Volume | 0 |
| Revenue (TTM) | $825.37M |
| Net Income | $-60.01M |
| Gross Margin | 70.75% |
4 analysts cover OFIX: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $17.25.